A detailed history of Lgt Financial Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lgt Financial Advisors LLC holds 546 shares of BMY stock, worth $30,739. This represents 0.07% of its overall portfolio holdings.

Number of Shares
546
Previous 759 28.06%
Holding current value
$30,739
Previous $31.5 Million 10.44%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

SELL
$39.66 - $51.75 $8,447 - $11,022
-213 Reduced 28.06%
546 $28.2 Million
Q2 2024

Aug 05, 2024

BUY
$40.25 - $52.99 $9,136 - $12,028
227 Added 42.67%
759 $31.5 Million
Q1 2024

May 02, 2024

BUY
$47.98 - $54.4 $335 - $380
7 Added 1.33%
532 $28.8 Million
Q4 2023

Feb 12, 2024

SELL
$48.48 - $57.85 $678 - $809
-14 Reduced 2.6%
525 $27 Million
Q3 2023

Nov 01, 2023

BUY
$57.89 - $64.73 $31,202 - $34,889
539 New
539 $31.3 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Lgt Financial Advisors LLC Portfolio

Follow Lgt Financial Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lgt Financial Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lgt Financial Advisors LLC with notifications on news.